Nuveen Asset Management’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $27.9M | Sell |
672,179
-9,998
| -1% | -$416K | 0.01% | 965 |
|
|
2024
Q3 | $45.6M | Sell |
682,177
-63,923
| -9% | -$4.27M | 0.01% | 708 |
|
|
2024
Q2 | $88.6M | Sell |
746,100
-60,194
| -7% | -$7.15M | 0.03% | 439 |
|
|
2024
Q1 | $85.9M | Sell |
806,294
-114,355
| -12% | -$12.2M | 0.03% | 458 |
|
|
2023
Q4 | $91.6M | Sell |
920,649
-38,413
| -4% | -$3.82M | 0.03% | 421 |
|
|
2023
Q3 | $99.1M | Sell |
959,062
-10,352
| -1% | -$1.07M | 0.03% | 371 |
|
|
2023
Q2 | $118M | Sell |
969,414
-48,081
| -5% | -$5.84M | 0.04% | 340 |
|
|
2023
Q1 | $156M | Sell |
1,017,495
-11,978
| -1% | -$1.84M | 0.06% | 278 |
|
|
2022
Q4 | $185M | Buy |
1,029,473
+93,423
| +10% | +$16.8M | 0.07% | 249 |
|
|
2022
Q3 | $111M | Sell |
936,050
-61,815
| -6% | -$7.31M | 0.04% | 351 |
|
|
2022
Q2 | $143M | Sell |
997,865
-69,932
| -7% | -$9.99M | 0.06% | 302 |
|
|
2022
Q1 | $187M | Sell |
1,067,797
-12,767
| -1% | -$2.24M | 0.06% | 277 |
|
|
2021
Q4 | $274M | Sell |
1,080,564
-191,840
| -15% | -$48.7M | 0.08% | 219 |
|
|
2021
Q3 | $490M | Sell |
1,272,404
-207,313
| -14% | -$79.8M | 0.15% | 133 |
|
|
2021
Q2 | $348M | Buy |
1,479,717
+298,009
| +25% | +$70M | 0.1% | 185 |
|
|
2021
Q1 | $155M | Sell |
1,181,708
-165,428
| -12% | -$21.7M | 0.05% | 336 |
|
|
2020
Q4 | $141M | Buy |
1,347,136
+577,249
| +75% | +$60.3M | 0.05% | 350 |
|
|
2020
Q3 | $54.5M | Sell |
769,887
-299,121
| -28% | -$21.2M | 0.02% | 551 |
|
|
2020
Q2 | $68.6M | Buy |
1,069,008
+256,011
| +31% | +$16.4M | 0.03% | 473 |
|
|
2020
Q1 | $24.3M | Buy |
812,997
+89,937
| +12% | +$2.69M | 0.01% | 796 |
|
|
2019
Q4 | $13.8M | Sell |
723,060
-14,651
| -2% | -$279K | 0.01% | 1395 |
|
|
2019
Q3 | $11.7M | Buy |
737,711
+643,967
| +687% | +$10.2M | ﹤0.01% | 1463 |
|
|
2019
Q2 | $1.37M | Buy |
+93,744
| New | +$1.37M | ﹤0.01% | 2610 |
|